Research location
Oakville
Ontario, Canada
Advertisement
Research activity in Oakville
Ontario, CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 166 trials and 173 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Oakville
166 linked trials · page 2 of 4EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)NCT03057977 · 2017-03-06 · 1 site observation
COMPLETED
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)NCT03057951 · 2017-03-02 · 1 site observation
COMPLETED
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate CancerNCT04060043 · 2017-02-21 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart FailureNCT03036124 · 2017-02-08 · 1 site observation
COMPLETED
Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)NCT02987543 · 2017-02-06 · 1 site observation
COMPLETED
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 DiabetesNCT02825251 · 2016-07-06 · 1 site observation
COMPLETED
Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD StationNCT02856633 · 2016-07-01 · 1 site observation
COMPLETED
PAtient RegisTry Assessing Effectiveness and Safety of HEart Failure treatmeNt With LCZ696 acrOss CaNadaNCT02957409 · 2016-05-20 · 1 site observation
COMPLETED
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular DiseaseNCT02663908 · 2016-04-19 · 1 site observation
TERMINATED
A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)NCT02677896 · 2016-03-09 · 1 site observation
COMPLETED
Randomized Trial Comparing Colesevelam vs. EzetimibeNCT02682680 · 2016-01-11 · 1 site observation
COMPLETED
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From RemicadeNCT02605642 · 2015-09-10 · 1 site observation
COMPLETED
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy AloneNCT02531035 · 2015-09-01 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 DiabetesNCT02413398 · 2015-06-15 · 1 site observation
COMPLETED
Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and OlderNCT02392754 · 2015-04-01 · 1 site observation
COMPLETED
Observational Study of Golimumab Intravenous InfusionNCT02390700 · 2015-02-01 · 1 site observation
TERMINATED
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)NCT02257736 · 2014-11-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes MellitusNCT02229227 · 2014-11-21 · 1 site observation
COMPLETED
A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology SettingNCT02364531 · 2014-09-30 · 1 site observation
COMPLETED
A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM)NCT02139943 · 2014-05-01 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk FactorsNCT02019264 · 2014-01-24 · 2 site observations
COMPLETED
Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop RecorderNCT02401854 · 2014-01-01 · 1 site observation
COMPLETED
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 DiabetesNCT01836523 · 2013-11-01 · 1 site observation
COMPLETED
PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness TrainingNCT04057859 · 2013-11-01 · 2 site observations
COMPLETED
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate CancerNCT01946204 · 2013-10-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of Diet and Exercise in Prostate Cancer PatientsNCT01960881 · 2013-09-19 · 1 site observation
COMPLETED
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With EtanerceptNCT01875991 · 2013-06-05 · 1 site observation
COMPLETED
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular EventsNCT01730534 · 2013-04-25 · 1 site observation
COMPLETED
Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 DiabetesNCT01829477 · 2013-04-01 · 1 site observation
TERMINATED
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation
TERMINATED
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension StudyNCT01436175 · 2012-02-27 · 1 site observation
TERMINATED
A Study in Participants With Type I Diabetes MellitusNCT01454284 · 2012-01-01 · 1 site observation
COMPLETED
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 DiabetesNCT01481116 · 2012-01-01 · 1 site observation
TERMINATED
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerNCT01322490 · 2011-11-28 · 1 site observation
COMPLETED
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderNCT01436149 · 2011-10-27 · 1 site observation
COMPLETED
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)NCT01394952 · 2011-07-22 · 1 site observation
COMPLETED
12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes MellitusNCT01370005 · 2011-06-01 · 1 site observation
COMPLETED
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque PsoriasisNCT01276639 · 2011-03-01 · 1 site observation
COMPLETED
Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH AgonistsNCT01366053 · 2011-03-01 · 1 site observation
COMPLETED
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerNCT01234311 · 2011-03-01 · 1 site observation
COMPLETED
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 DiabetesNCT01289990 · 2011-02-01 · 1 site observation
COMPLETED
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt NephropathyNCT01200394 · 2010-12-01 · 1 site observation
COMPLETED
OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump TherapyNCT01182493 · 2010-12-01 · 1 site observation
COMPLETED
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisNCT01163253 · 2010-09-01 · 1 site observation
TERMINATED
Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 DiabetesNCT01159600 · 2010-07-01 · 1 site observation
COMPLETED
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesNCT01149421 · 2010-06-01 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes MellitusNCT01106651 · 2010-06-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes AdultsNCT01103284 · 2010-04-01 · 1 site observation
COMPLETED
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone LossNCT00925600 · 2009-11-30 · 1 site observation
COMPLETED
Eligard Observational Registry for Patients With Prostate CancerNCT00992251 · 2009-08-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.